Ceribell

About:

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Website: https://www.ceribell.com

Top Investors: RA Capital Management, Horizon Technology Finance, Longitude Capital, The Rise Fund, LivaNova

Description:

Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective. The company creates and validates an FDA cleared instant EEG system that does not require an EEG technologist or specialist interpreter, which allows for faster results and clinical decision-making. The Ceribell EEG System can be set up by any healthcare provider in 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening. Earlier diagnosis and focused treatment for patients with seizures, including non-convulsive seizures that can only be diagnosed with EEG, can significantly lower mortality, secondary brain injury, length of stay, and risk of complications.

Total Funding Amount:

$171M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mountain View, California, United States

Founded Date:

2014-01-01

Contact Email:

EEG(AT)ceribell.com

Founders:

Chris Chafe, Josef Parvizi, Xingjuan Chao

Number of Employees:

101-250

Last Funding Date:

2022-09-21

IPO Status:

Public

Industries:

© 2025 bioDAO.ai